PRODUCT INFORMATION
Description
CGGRGD TFA (Cys-Gly-Gly-Arg-Gly-Asp) is a cysteine-terminated hexapeptide featuring the tripeptide Arg-Gly-Asp (RGD) motif. This sequence serves as an integrin-binding domain that mediates cellular adhesion in vitro via interactions with αvβ3/αvβ5 integrin receptors. This synthetic peptide combines RGD's ECM-recognition functionality with an N-terminal cysteine for easy conjugation.
Molecular Weight
677.61
Purity
> 95%
Formula
C₂₁H₃₄F₃N₉O₁₁S
Product Type
Targeting Peptide
Sequence
Cys-Gly-Gly-Arg-Gly-Asp
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- CGGRGD Targeting Peptide (CAT#: OLY-1025-YS-26)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- Thrombin-cleavable Targeting Peptide (CAT#: OLY-1025-YS-34)
- GPLGLAGGWGERDGS Targeting Peptide (CAT#: OLY-1025-YS-25)
- 293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- Octreotide Targeting Peptide (CAT#: OLY-1025-YS-3)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.